Compare NMIH & VCYT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | NMIH | VCYT |
|---|---|---|
| Founded | 2011 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Property-Casualty Insurers | Medical Specialities |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.8B | 3.1B |
| IPO Year | 2013 | 2013 |
| Metric | NMIH | VCYT |
|---|---|---|
| Price | $41.92 | $59.30 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 4 | 7 |
| Target Price | $43.25 | ★ $44.00 |
| AVG Volume (30 Days) | 591.0K | ★ 1.3M |
| Earning Date | 04-30-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 11.06 | ★ 164.52 |
| EPS | ★ 1.28 | 0.35 |
| Revenue | ★ $706,440,000.00 | N/A |
| Revenue This Year | N/A | $13.76 |
| Revenue Next Year | $4.34 | $12.35 |
| P/E Ratio | ★ $32.70 | $170.20 |
| Revenue Growth | ★ 8.52 | N/A |
| 52 Week Low | $34.84 | $22.92 |
| 52 Week High | $43.36 | $60.91 |
| Indicator | NMIH | VCYT |
|---|---|---|
| Relative Strength Index (RSI) | 61.33 | 60.71 |
| Support Level | $36.61 | $40.27 |
| Resistance Level | $42.15 | $60.91 |
| Average True Range (ATR) | 0.93 | 2.96 |
| MACD | 0.03 | -0.42 |
| Stochastic Oscillator | 54.05 | 79.76 |
NMI Holdings Inc through its subsidiaries provides private mortgage guaranty insurance. The company offers mortgage insurance, reinsurance on loans, and outsourced loan review services to mortgage loan originators. It serves national and regional mortgage banks, money center banks, credit unions, community banks, builder-owned mortgage lenders, Internet-sourced lenders, and other non-bank lenders. It protects lenders and investors from default-related losses on a portion of the unpaid principal balance of a covered mortgage.
Veracyte Inc is a genomic diagnostics company. The group empowers clinicians with the insights necessary to guide and assure patients at pivotal moments in the race to diagnose and treat cancer. It offers tests for prostate cancer (Decipher Prostate), thyroid cancer (Afirma), breast cancer (Prosigna), and bladder cancer (Decipher Bladder).